Exercise Capacity in Patients with the Total Artificial Heart.


Journal

ASAIO journal (American Society for Artificial Internal Organs : 1992)
ISSN: 1538-943X
Titre abrégé: ASAIO J
Pays: United States
ID NLM: 9204109

Informations de publication

Date de publication:
01 2019
Historique:
pubmed: 13 1 2018
medline: 11 2 2020
entrez: 12 1 2018
Statut: ppublish

Résumé

There is a dearth of information regarding the functional abilities of patients with the total artificial heart (TAH). Increased utilization of the TAH and patient discharge to home with the portable unit necessitates a shift in focus to quality of life, which includes quantifying and ultimately optimizing functional capacity. To date, only single-patient case studies have described the exercise response of the TAH patient. Fourteen patients with the TAH underwent cardiopulmonary exercise testing with concurrent analysis of TAH device function. All device settings remained fixed during testing. Peak oxygen consumption (VO2; 0.872 L/min [interquartile range (IQR) = 0.828-1.100 L/min]), percent predicted peak VO2 (36% [IQR = 32-42%]), and ventilatory anaerobic threshold (0.695 L/min [IQR = 0.542-0.845 L/min]) were markedly reduced in the TAH compared with predicted normal values. Determinants of VO2 using device-generated hemodynamics revealed a blunted cardiac output (+9% increase) and exaggerated oxygen extraction with exercise. Peak VO2 strongly correlated with resting (R = +0.548, p = 0.045), ventilatory anaerobic threshold (R = +0.780, p = 0.001), and peak exercise cardiac output (R = +0.672, p = 0.008). Patients with the TAH have significantly impaired exercise performance. The limitations to cardiopulmonary exercise testing performance appear to be related to limited ability of the pump to modulate output for activity and reduced oxygen carrying capacity.

Identifiants

pubmed: 29324512
doi: 10.1097/MAT.0000000000000746
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

36-42

Auteurs

Justin M Canada (JM)

From the Department of Kinesiology & Health Sciences, Virginia Commonwealth University, Richmond, Virginia.
Division of Cardiology, VCU Pauley Heart Center, Virginia Commonwealth University, Richmond, Virginia.

Ronald K Evans (RK)

From the Department of Kinesiology & Health Sciences, Virginia Commonwealth University, Richmond, Virginia.

Antonio Abbate (A)

Division of Cardiology, VCU Pauley Heart Center, Virginia Commonwealth University, Richmond, Virginia.

Ross Arena (R)

Department of Physical Therapy at the University of Illinois Chicago, Chicago, Illinois.

Daniel G Tang (DG)

Division of Cardiothoracic Surgery, VCU Pauley Heart Center, Virginia Commonwealth University, Richmond, Virginia.

Vigneshwar Kasirajan (V)

Division of Cardiothoracic Surgery, VCU Pauley Heart Center, Virginia Commonwealth University, Richmond, Virginia.

Keyur B Shah (KB)

Division of Cardiology, VCU Pauley Heart Center, Virginia Commonwealth University, Richmond, Virginia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH